Surgical Science Sweden AB (publ)

DB:4P41 Stock Report

Market Cap: €698.7m

Surgical Science Sweden Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 4P41?
Owner TypeNumber of SharesOwnership Percentage
General Public10,433,61920.4%
Individual Insiders13,594,43326.6%
Institutions26,998,18452.9%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 77.98% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Jan Bengtsson
7,138,371€97.7m0%no data
11.7%
Roland Bengtsson
5,992,338€82.1m0%no data
6.66%
Handelsbanken Asset Management
3,399,929€46.6m0%0.07%
6.49%
Swedbank Robur Fonder AB
3,310,000€45.3m0%0.03%
6.41%
Capital Research and Management Company
3,271,137€44.8m0%no data
5.29%
Teknik Innovation Norden Fonder AB
2,700,000€37.0m0%16.96%
5.24%
Fourth Swedish National Pension Fund (AP4)
2,675,753€36.6m0%0.16%
5%
Kirkbi Invest A/S
2,550,961€34.9m0%4.87%
2.25%
Montanaro Asset Management Ltd.
1,150,154€15.7m0%0.63%
2.2%
Amundi Asset Management SAS
1,124,960€15.4m4.87%no data
1.82%
Joh. Berenberg, Gossler & Co. KG, Asset Management Arm
928,991€12.7m0%0.49%
1.52%
Andra AP-fonden
776,518€10.6m0%0.06%
1.09%
Nordea Investment Management, AB
557,611€7.6m0%0.01%
1.04%
Columbia Management Investment Advisers, LLC
532,980€7.3m0%no data
1.04%
Carnegie Fonder AB
532,646€7.3m0%0.08%
0.8%
BNPP Asset Management Holding
409,001€5.6m0%0.01%
0.74%
Humle Kapitalförvaltning AB
375,218€5.1m0%1.42%
0.71%
BlackRock, Inc.
360,229€4.9m-4.01%no data
0.7%
Enter Fonder AB
359,401€4.9m0%0.82%
0.67%
Gisli Hennermark
342,200€4.7m0%no data
0.59%
CM-CIC Asset Management SA
300,546€4.1m0%0.1%
0.53%
Ålandsbanken Fondbolag AB
271,615€3.7m0%0.16%
0.53%
Phoenix Asset Management Partners Ltd.
269,610€3.7m0%0.27%
0.46%
Mandatum Asset Management Oy
236,281€3.2m0%2.22%
0.44%
Lonvia Capital
222,430€3.0m0%1.28%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 08:26
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Surgical Science Sweden AB (publ) is covered by 5 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Simon JonssonBerenberg
Viktor HögbergDanske Bank
Jonatan AnderssonDNB Markets